Your browser doesn't support javascript.
loading
The Neuroprotective Marine Compound Psammaplysene A Binds the RNA-Binding Protein HNRNPK.
Boccitto, Marco; Lee, Nayoung; Sakamoto, Satoshi; Spruce, Lynn A; Handa, Hiroshi; Clardy, Jon; Seeholzer, Steven H; Kalb, Robert G.
Afiliação
  • Boccitto M; Department of Pediatrics, Division of Neurology, Research Institute, Children's Hospital of Philadelphia, Room 814, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. marco.boccitto@nih.gov.
  • Lee N; Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. marco.boccitto@nih.gov.
  • Sakamoto S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA. nayoung.lee@genex.co.kr.
  • Spruce LA; School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa 226-8501, Japan. ssakamoto@bio.titech.ac.jp.
  • Handa H; Children's Hospital of Philadelphia Research Institute, Protein and Proteomics Core, Philadelphia, PA 19104, USA. spruce@email.chop.edu.
  • Clardy J; Department of Nanoparticle Translational Research, Tokyo Medical University 6-1-1, Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. hhanda@tokyo-med.ac.jp.
  • Seeholzer SH; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA. jon_clardy@hms.harvard.edu.
  • Kalb RG; Children's Hospital of Philadelphia Research Institute, Protein and Proteomics Core, Philadelphia, PA 19104, USA. seeholzer@email.chop.edu.
Mar Drugs ; 15(8)2017 Aug 07.
Article em En | MEDLINE | ID: mdl-28783126
ABSTRACT
In previous work, we characterized the strong neuroprotective properties of the marine compound Psammaplysene A (PA) in in vitro and in vivo models of neurodegeneration. Based on its strong neuroprotective activity, the current work attempts to identify the physical target of PA to gain mechanistic insight into its molecular action. Two distinct methods, used in parallel, to purify protein-binding partners of PA led to the identification of HNRNPK as a direct target of PA. Based on surface plasmon resonance, we find that the binding of PA to HNRNPK is RNA-dependent. These findings suggest a role for HNRNPK-dependent processes in neurodegeneration/neuroprotection, and warrant further study of HNRNPK in this context.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Proteínas de Ligação a RNA / Fármacos Neuroprotetores / Ribonucleoproteínas Nucleares Heterogêneas Grupo K Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tirosina / Proteínas de Ligação a RNA / Fármacos Neuroprotetores / Ribonucleoproteínas Nucleares Heterogêneas Grupo K Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos